ESC 365 - Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator

EHRA Premium Access

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator

Session: News on ICDs

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor I. Crozier (Christchurch, NZ)

Event: EHRA 2022

Congress Presentation

About the speaker

Doctor Ian Crozier

Christchurch Hospital, Christchurch (New Zealand)

1 presentation

2 followers

5 more presentations in this session

Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients. Insights from a multicenter registry

Speaker: Doctor J. Luker (Cologne, DE)

Impact of generic ICD programming on clinical outcomes

Speaker: Mrs P. Khan (London, GB)

S-ICD in heart failure patients: real-world data from a multicenter, european analysis

Speaker: Doctor M. Schiavone (Milan, IT)

In-silico optimisation of ICD defibrillation efficacy by modifying lead/can configurations using a cohort of high-resolution whole-torso heart models

Speaker: Doctor S. Qian (London, GB)

Delayed detection programming significantly reduces inappropriate ICD therapies in patients with left-ventricular assist devices.

Speaker: Doctor S. Hohmann (Hannover, DE)

Access the full session

News on ICDs

Speakers: Doctor I. Crozier, Doctor J. Luker, Mrs P. Khan, Doctor M. Schiavone, Doctor S. Qian...

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

Related content

EHRA Premium Access

Vascular access and lead placement: minimise complications with a view to long-term lead performance.

4 April 2022

EHRA Premium Access

EHRA expect consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

3 April 2022

EHRA Premium Access

EHRA position paper on leadless pacing and extravascular defibrillators.

3 April 2022

ESC 365 is supported by